Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pozzilli

Showing results (151-160 of 187) with videos related to

Pageof 19
Sort By:
Brain : a Journal of Neurology|June 16, 2001
T(1) hypointense lesions in secondary progressive multiple sclerosis: effect of interferon beta-1b treatmentF Barkhof, J H van Waesberghe, M Filippi, et al.
Mediators of Inflammation|August 4, 2015
Relationship between Prolactin Plasma Levels and White Matter Volume in Women with Multiple SclerosisL De Giglio, F Marinelli, L Prosperini, et al.
AJNR. American Journal of Neuroradiology|April 1, 1997
Fast spin-echo and fast fluid-attenuated inversion-recovery versus conventional spin-echo sequences for MR quantification of multiple sclerosis lesionsS Bastianello, A Bozzao, A Paolillo, et al.
Journal of Neurology|March 1, 1997
Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcomeE Millefiorini, C Gasperini, C Pozzilli, et al.
European Journal of Neurology|February 1, 2017
Survey of diagnostic and treatment practices for multiple sclerosis in EuropeO Fernández, M Delvecchio, G Edan, et al.
European Journal of Neurology|January 23, 2018
Survey of diagnostic and treatment practices for multiple sclerosis (MS) in Europe. Part 2: Progressive MS, paediatric MS, pregnancy and general managementO Fernández, M Delvecchio, G Edan, et al.
Brain : a Journal of Neurology|November 3, 1998
A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trialsM Filippi, M Rovaris, R Capra, et al.
Neurology|February 9, 2011
Serum elements and oxidative status in clinically isolated syndromes: imbalance and predictivityG Ristori, S Brescianini, A Pino, et al.
Neuroimage|October 1, 1996
Functional basis of memory impairment in multiple sclerosis: a[18F]FDG PET studyE Paulesu, D Perani, F Fazio, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 2013
Natalizumab in pediatric multiple sclerosis: results of a cohort of 55 casesA Ghezzi, C Pozzilli, L M E Grimaldi, et al.
Pageof 19

Showing results (151-160 of 187) with videos related to

Sort By:
Pageof 19
Brain : a Journal of Neurology|June 16, 2001
T(1) hypointense lesions in secondary progressive multiple sclerosis: effect of interferon beta-1b treatmentF Barkhof, J H van Waesberghe, M Filippi, et al.
Mediators of Inflammation|August 4, 2015
Relationship between Prolactin Plasma Levels and White Matter Volume in Women with Multiple SclerosisL De Giglio, F Marinelli, L Prosperini, et al.
AJNR. American Journal of Neuroradiology|April 1, 1997
Fast spin-echo and fast fluid-attenuated inversion-recovery versus conventional spin-echo sequences for MR quantification of multiple sclerosis lesionsS Bastianello, A Bozzao, A Paolillo, et al.
Journal of Neurology|March 1, 1997
Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcomeE Millefiorini, C Gasperini, C Pozzilli, et al.
European Journal of Neurology|February 1, 2017
Survey of diagnostic and treatment practices for multiple sclerosis in EuropeO Fernández, M Delvecchio, G Edan, et al.
European Journal of Neurology|January 23, 2018
Survey of diagnostic and treatment practices for multiple sclerosis (MS) in Europe. Part 2: Progressive MS, paediatric MS, pregnancy and general managementO Fernández, M Delvecchio, G Edan, et al.
Brain : a Journal of Neurology|November 3, 1998
A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trialsM Filippi, M Rovaris, R Capra, et al.
Neurology|February 9, 2011
Serum elements and oxidative status in clinically isolated syndromes: imbalance and predictivityG Ristori, S Brescianini, A Pino, et al.
Neuroimage|October 1, 1996
Functional basis of memory impairment in multiple sclerosis: a[18F]FDG PET studyE Paulesu, D Perani, F Fazio, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 2013
Natalizumab in pediatric multiple sclerosis: results of a cohort of 55 casesA Ghezzi, C Pozzilli, L M E Grimaldi, et al.
Pageof 19